Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma 11Lymphoma, Non-Hodgkin 9Lymphoma, Large B-Cell, Diffuse 9Burkitt Lymphoma 9Myelodysplastic Syndromes 8Lymphoma, Follicular 8Leukemia, Lymphocytic, Chronic, B-Cell 8Multiple Myeloma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Acute 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Hodgkin Disease 6Blast Crisis 6Recurrence 5Neoplasms, Plasma Cell 5Leukemia, Myeloid, Accelerated Phase 5Graft vs Host Disease 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Myeloproliferative Disorders 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Juvenile 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Hematologic Neoplasms 3

Interventions

fludarabine phosphate 10Whole-Body Irradiation 8Peripheral Blood Stem Cell Transplantation 8Cyclophosphamide 8Busulfan 8Mycophenolic Acid 7Tacrolimus 6Antilymphocyte Serum 6Methotrexate 5Cyclosporine 5Melphalan 4Etoposide 4thymoglobulin 3Sirolimus 3Rituximab 3Radiotherapy 3Cord Blood Stem Cell Transplantation 3fludarabine 2Ondansetron 2Granulocyte Colony-Stimulating Factor 2Dexamethasone 2Cytarabine 2Cyclosporins 2Carmustine 2Calcium Dobesilate 2Aprepitant 2rasburicase 1etoposide phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pdgfra-Associated Chronic Eosinophilic Leukemia × Methylprednisolone × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡